Blog
About

0
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      Good Response of Endogenous Erythropoietin to Blood Loss in Persistently ImprovingRenal Anemia after Discontinuation ofErythropoietin Treatment

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Author and article information

          Journal
          NEF
          Nephron
          10.1159/issn.1660-8151
          Nephron
          S. Karger AG
          1660-8151
          2235-3186
          1999
          1999
          13 January 1999
          : 81
          : 1
          : 111-112
          Affiliations
          aSecond Department of Internal Medicine, Yokohama City University School of Medicine, bSecond Department of Internal Medicine, Yokohama Minami Kyosai Hospital, cBousei Kannai Clinic, dKousaikai Asahi Hospital, Yokohama, Japan
          Article
          45259 Nephron 1999;81:111–112
          10.1159/000045259
          9884433
          © 1999 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          Page count
          Figures: 2, References: 7, Pages: 2
          Product
          Self URI (application/pdf): https://www.karger.com/Article/Pdf/45259
          Categories
          Letter to the Editor

          Cardiovascular Medicine, Nephrology

          Comments

          Comment on this article